I Like JD Vance So Much That I Want Him Primaried Hard
Democrats Are Making a New Martyr
Talking Heads Are Missing Labor Market Strength
Trump Is Minnesota's President, Too
Can Republicans Defy History in 2026?
Watching History Unfold
Conflicting Thoughts on Venezuela From a Pat Buchanan and Ron Paul Noninterventionist
Will President Trump Push for Real Change at CNN?
Real Protests vs Fake Protests
Iran Does Not Need a Crown — It Needs a Republic
Litigation Funding Helps Level the Legal Playing Field
The Anti-Energy Litigation Industry’s Surprising Ally? Louisiana’s Republican Attorney Gen...
Kristi Noem Torches CNN’s Jake Tapper in Fiery Clash Over Minneapolis ICE Shooting
Miami Jury Convicts Two Executives in $34M Medicare Advantage Brace Fraud Scheme
Chinese National With Overstayed Visa Charged as Ringleader in Firearms Conspiracy
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement